China Regenerative Medicine International Limited (HKG:8158)

Market Cap	66.94M -75.3%
Revenue (ttm)	72.06M -20.5%
Net Income	27.53M +55.1%
EPS	0.09 +55.2%
Shares Out	304.25M
PE Ratio	2.43
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	159,200
Open	0.2320
Previous Close	0.2270
Day's Range	0.2100 - 0.2320
52-Week Range	0.2100 - 1.0900
Beta	-0.64
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About HKG:8158

China Regenerative Medicine International Limited, together with its subsidiaries, engages in the research, development, production, and sale of tissue engineering and regenerative medicine products in Hong Kong and China. It operates in two segments, Aesthetic Medical and Beauty Services, and Medical Services. The company offers anti-aging /prevention, functional medicine and solutions, and treatment and diagnosis; hair regenerating medical solutions; and zoom consultation, mental fog therapy, physiotherapy, acnes treatment, and facial and sli...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 30
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 8158

Financial Performance

In 2025, HKG:8158's revenue was 72.06 million, a decrease of -20.48% compared to the previous year's 90.62 million. Earnings were 27.53 million, an increase of 55.05%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 4, 2026

Data Sources Report a data error